கையால் எழுதப்பட்ட தாள் ஒன்றுபட்டது மாநிலங்களில் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article
Share this article
PISCATAWAY, N.J., Feb. 11, 2021 /PRNewswire/ GenScript USA Inc., the world s leading life science research tools and services provider,
 announced today that it has received Emergency Use Authorization by the U.S. Food and Drug Administration s Center for Biologics Evaluation and Research (CBER) for use of the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit in convalescent plasma screening. The cPass kit is the first FDA authorized test that specifically detects COVID-19 neutralizing antibodies without the use of live virus. Neutralizing antibodies block the ability of the virus to infect a cell and are widely recognized biomarkers of immunity. ....

Hong Kong , New Jersey , United States , Ministry Of Health , United Arab Emirates , Sean Taylor , David Martz , Genscript United States Inc , Genscript Biotech Corporation , Life Science Group At Genscript , Prnewswire Genscript United States Inc , Genscript Biotech Corporation Stock Code , Hong Kong Stock Exchange , Health Sciences Authorities , Drug Administration Center , Script United States Inc , Emergency Use Authorization , Drug Administration , Biologics Evaluation , Antibody Detection Kit , Life Science Group , Clinical Microbiology , United Arab , Script Biotech Corporation , Stock Code , Mainland China ,